Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Sigma A6730 | 3.0 | uM | 1 | IL-9 | 89.0 | 55 | ||||
RA2159 | IL-17A | 100 | ng/mL | 1 | IL-9 | 286.0 | 74 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | IL-9 | 336.0 | 60 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | IL-9 | 331.5 | 76 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | IL-9 | 493.0 | 74 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | IL-9 | 530.0 | 70 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | IL-9 | 541.0 | 83 | |
N2586 | IL-17A | 100 | ng/mL | 1 | IL-9 | 844.0 | 83 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | IL-9 | 499.0 | 57 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | IL-9 | 378.0 | 80 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | IL-9 | 434.0 | 93 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | IL-9 | 478.0 | 62 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | IL-9 | 440.0 | 72 | |
RA2159 | 1 | IL-9 | 86.0 | 85 | |||||||
RA2159 | PD184352 | 0.1 | uM | 1 | IL-9 | 67.0 | 69 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 1 | IL-9 | 65.0 | 79 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 1 | IL-9 | 86.5 | 66 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 1 | IL-9 | 83.5 | 80 | ||||
RA2159 | IKK16 | 2.0 | uM | 1 | IL-9 | 69.0 | 78 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 1 | IL-9 | 78.5 | 60 | ||||
N2586 | 1 | IL-9 | 75.0 | 73 | |||||||
N2586 | PD184352 | 0.1 | uM | 1 | IL-9 | 66.0 | 54 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 1 | IL-9 | 95.0 | 61 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 1 | IL-9 | 82.0 | 54 | ||||
N2586 | Tofacitinib | 0.3 | uM | 1 | IL-9 | 96.5 | 52 |